115 related articles for article (PubMed ID: 6184823)
1. Pharmacokinetics of interferons. A reappraisal.
Bocci V
Tex Rep Biol Med; 1981-1982; 41():336-43. PubMed ID: 6184823
[No Abstract] [Full Text] [Related]
2. Metabolism of interferon (facts and fancy).
Bocci V; Pacini A; Pessina GP; Bargigli V
Ric Clin Lab; 1978; 8(1-2):17-25. PubMed ID: 705176
[TBL] [Abstract][Full Text] [Related]
3. Biologicals for cancer treatment: interferons.
Oldham RK
Hosp Pract (Off Ed); 1985 Dec; 20(12):71-4, 78-81, 85-6 passim. PubMed ID: 2415542
[No Abstract] [Full Text] [Related]
4. [The pharmacokinetics of interferons].
Ogarkov VI; Lapina GF
Antibiot Med Biotekhnol; 1986 Sep; 31(9):712-5. PubMed ID: 2430520
[No Abstract] [Full Text] [Related]
5. [Pharmacokinetics and pharmacological aspects of interferons].
Kiuch Y
Gan To Kagaku Ryoho; 1984 Jan; 11(1):36-43. PubMed ID: 6421242
[TBL] [Abstract][Full Text] [Related]
6. Degradation of human 125I-interferon alpha by isolated perfused rabbit kidney and liver.
Bocci V; Mogensen KE; Muscettola M; Pacini A; Paulesu L; Pessina GP; Skiftas S
J Lab Clin Med; 1983 Jun; 101(6):857-63. PubMed ID: 6854125
[TBL] [Abstract][Full Text] [Related]
7. Interactions between body fluids, chemotherapeutic agents and interferon.
Cesario TC; Tilles JG
Tex Rep Biol Med; 1981-1982; 41():259-62. PubMed ID: 6184812
[No Abstract] [Full Text] [Related]
8. Distribution of interferon in body fluids and tissues.
Bocci V
Tex Rep Biol Med; 1977; 35():436-42. PubMed ID: 358467
[No Abstract] [Full Text] [Related]
9. Catabolic sites of human interferon-gamma.
Bocci V; Pacini A; Pessina GP; Paulesu L; Muscettola M; Lunghetti G
J Gen Virol; 1985 Apr; 66 ( Pt 4)():887-91. PubMed ID: 3920351
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of rat fibroblast interferon.
Abreu SL
J Pharmacol Exp Ther; 1983 Jul; 226(1):197-200. PubMed ID: 6191024
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of type-I- and type-II-interferon-mediated signalling.
Platanias LC
Nat Rev Immunol; 2005 May; 5(5):375-86. PubMed ID: 15864272
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of human interferons].
Furue H; Kobayashi H; Komuro T; Kako M; Mugitani H; Fuse K; Kaise R; Nagai K; Takahashi T; Hirota F
Gan To Kagaku Ryoho; 1984 Apr; 11(4):935-42. PubMed ID: 6721508
[TBL] [Abstract][Full Text] [Related]
13. Catabolism of interferons.
Bocci V
Surv Immunol Res; 1982; 1(2):137-43. PubMed ID: 6195713
[No Abstract] [Full Text] [Related]
14. [Study of the catabolism of interferon, using the isolated and perfused liver].
Pessina GP; Pacini A; Bargigli V; Russi-Sorce M; Bocci V
Boll Soc Ital Biol Sper; 1976 May; 52(10):651-7. PubMed ID: 949376
[No Abstract] [Full Text] [Related]
15. Interferon expression by B cells.
Young HA
Methods; 1997 Jan; 11(1):112-5. PubMed ID: 8990096
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of interferon in viral infections.
Levin S
Isr J Med Sci; 1983 Nov; 19(11):955-8. PubMed ID: 6198305
[No Abstract] [Full Text] [Related]
17. Interferons as anticancer agents.
Brodsky I; Hubbell HR
Am Fam Physician; 1984 Jun; 29(6):246-8. PubMed ID: 6203394
[No Abstract] [Full Text] [Related]
18. Which will be the most useful interferon?
Bocci V
Ric Clin Lab; 1981; 11(1):27-32. PubMed ID: 6164090
[TBL] [Abstract][Full Text] [Related]
19. [Appearance and determination of interferon in the bile of rabbits].
Bargigli V; Russi-Sorce M; Pacini A; Pessina GP; Bocci V
Boll Soc Ital Biol Sper; 1977 May; 53(9):684-9. PubMed ID: 911516
[No Abstract] [Full Text] [Related]
20. [Therapy of chronic active hepatitis B (CAHB) with interferons].
Müller R; Siegert W; Hofschneider HP; Deinhardt F; Frösner G; Korb G; Vido I; Schmidt FW
Z Gastroenterol Verh; 1982 Apr; 17():105-9. PubMed ID: 6191453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
